Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosis

Mult Scler Relat Disord. 2024 Jan:81:105364. doi: 10.1016/j.msard.2023.105364. Epub 2023 Dec 10.
No abstract available

Keywords: ATA188; EBV; Progressive multiple sclerosis; T-cell therapies.

Publication types

  • Editorial

MeSH terms

  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human
  • Humans
  • Multiple Sclerosis* / drug therapy

Associated data

  • ClinicalTrials.gov/NCT03283826